TEVA Teva Pharmaceutical Industries Limited Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

TEVA [NYSE]

Teva Pharmaceutical Industries Limited

Healthcare | Drug Manufacturers - Specialty & Generic | Israel

statements

Index	-	P/E	2880.00	EPS (ttm)	0.00	Insider Own	0.60%	Shs Outstand	1.10B	Perf Week	-5.98%
Market Cap	9.30B	Forward P/E	3.28	EPS next Y	2.63	Insider Trans	-0.05%	Shs Float	1.09B	Perf Month	-10.28%
Income	4.00M	PEG	900.00	EPS next Q	0.59	Inst Own	53.20%	Short Float	2.11%	Perf Quarter	-31.65%
Sales	16.48B	P/S	0.56	EPS this Y	59.40%	Inst Trans	5.70%	Short Ratio	2.59	Perf Half Y	10.20%
Book/sh	12.64	P/B	0.68	EPS next Y	4.90%	ROA	0.00%	Target Price	12.19	Perf Year	22.73%
Cash/sh	2.23	P/C	3.87	EPS next 5Y	3.20%	ROE	0.00%	52W Range	6.25 - 13.76	Perf YTD	-11.84%
Dividend	-	P/FCF	10.40	EPS past 5Y	-17.70%	ROI	-0.40%	52W High	-37.21%	Beta	1.47
Dividend %	-	Quick Ratio	0.70	Sales past 5Y	-3.60%	Gross Margin	46.40%	52W Low	38.24%	ATR	0.40
Employees	40039	Current Ratio	1.10	Sales Q/Q	-7.30%	Oper. Margin	2.60%	RSI (14)	33.11	Volatility	4.19% 4.06%
Optionable	Yes	Debt/Eq	1.90	EPS Q/Q	120.20%	Profit Margin	0.00%	Rel Volume	1.27	Prev Close	8.85
Shortable	Yes	LT Debt/Eq	1.78	Earnings	Aug 05 BMO	Payout	0.00%	Avg Volume	8.89M	Price	8.64
Recom	2.80	SMA20	-6.44%	SMA50	-18.88%	SMA200	-19.23%	Volume	11,260,859	Change	-2.37%

Aug-06-20

Upgrade

Barclays

Underweight → Equal Weight

$10 → $13

Jul-27-20

Resumed

Goldman

Neutral

$12

Jun-01-20

Upgrade

SunTrust

Hold → Buy

Apr-24-20

Resumed

Citigroup

Neutral

$10

Apr-06-20

Upgrade

UBS

Neutral → Buy

$14 → $12

Feb-24-20

Downgrade

Edward Jones

Hold → Sell

Nov-12-19

Upgrade

JP Morgan

Underweight → Neutral

Oct-17-19

Upgrade

Gabelli & Co

Hold → Buy

Aug-07-19

Downgrade

Evercore ISI

Outperform → In-line

Jul-19-19

Initiated

Wolfe Research

Peer Perform

Jul-15-19

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Jul-10-19

Resumed

Credit Suisse

Neutral

Jul-05-19

Upgrade

Argus

Hold → Buy

Jun-11-19

Initiated

Barclays

Underweight

Jun-03-19

Upgrade

Oppenheimer

Perform → Outperform

$12

May-30-19

Downgrade

BofA/Merrill

Buy → Underperform

May-28-19

Downgrade

UBS

Buy → Neutral

Mar-20-19

Initiated

SunTrust

Hold

Mar-07-19

Resumed

UBS

Buy

$22

Mar-06-19

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$17

Sep-23-20 08:20PM	Pomerantz Law Firm Announces the Filing of a Class Action against Teva Pharmaceuticals Industries Limited and Certain Officers - TEVA PR Newswire
07:13PM	Teva New Case Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The Firm Newsfile
Sep-22-20 07:31AM	Teva Launches Two Digital Inhalers For Asthma Patients SmarterAnalyst
Sep-21-20 08:00AM	Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Business Wire -5.59%
Sep-19-20 03:49PM	3 Top Stocks You Can Buy and Hold for the Next Decade Motley Fool
Sep-16-20 07:21AM	3 Bargain-Bin Buffett Stocks to Buy Right Now Motley Fool
Sep-15-20 08:00AM	First Long-Term Data on the use of AJOVY® (fremanezumab-vfrm) Injection in Patients with Migraine Published in Neurology Business Wire
06:06AM	5 "Buffett Stocks" Buffett Didn't Actually Buy Motley Fool
12:18AM	Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA) Insider Monkey
Sep-14-20 08:00AM	Teva to Present New Data at The MDS Virtual Congress 2020 and Psych Congress 2020 Virtual Experience Evaluating Long-Term Treatment with AUSTEDO® (deutetrabenazine) Tablets Business Wire
Sep-08-20 11:57AM	Teva Pharmaceuticals (TEVA) Has Risen 19% in Last One Year, Outperforms Market Insider Monkey
08:00AM	Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at the MDS Virtual Congress 2020 and Psych Congress 2020 Virtual Experience Business Wire
Sep-02-20 07:36PM	Analyst Report: Teva Pharmaceutical Industries Limited Morningstar Research
01:21PM	7 Cheap Stocks for the Cash-Strapped Investor InvestorPlace
Aug-26-20 03:35PM	Teva Analyst Estimates $1B In Price-Fixing Liability Following DOJ Indictment Benzinga
02:20PM	Teva's stock rises as the drugmaker defends against price-fixing allegations MarketWatch
12:50PM	U.S. authorities charge Teva in generic price-fixing probe Yahoo Finance Video
11:35AM	Teva Pharmaceutical Indicted on Charges of Generic Drugs Price-Fixing Motley Fool
08:55AM	Return On Capital Employed Overview: Teva Pharmaceutical Indus Benzinga
08:33AM	Teva Stock Down on Charges of Illegal Generic Price Fixing Zacks
03:15AM	Tevas U.S. Unit Charged in Generic-Drug Price-Fixing Probe Bloomberg
12:00AM	U.S. charges Teva in generic drugs price-fixing probe Reuters
Aug-25-20 10:42PM	US Indicts Teva Pharmaceutical In Generic Drug Price-Fixing Case Benzinga
08:39PM	Statement in Response to News of the Indictment of Teva USA Business Wire
04:22PM	U.S. charges Teva in generic drugs price-fixing probe Reuters
03:21PM	US charges ex-CEO of drug company with fraud tied to Teva tender offer Reuters
03:20PM	Teva Is Said to Face U.S. Charge in Price-Fixing Inquiry TheStreet.com
03:08PM	U.S. to charge Teva in generic drugs price-fixing probe: Bloomberg Law Reuters
03:01PM	Why Teva's Stock Is Trading Lower Today Benzinga
12:56PM	A Trio of Low Price-Book Ratio Stocks to Consider GuruFocus.com
Aug-24-20 07:24PM	Teva Pharmaceuticals Unit Actavis Generics Wins FDA Approval for Lung Cancer Drug Pemetrexed Motley Fool
Aug-22-20 11:40AM	Opioid crisis to cost $2.15 trillion? No amount of money can ever compensate for the pain Yahoo Finance
Aug-19-20 11:37AM	Looking Into Teva Pharmaceutical Indus's Return On Capital Employed Benzinga
08:31AM	Opioid Crisis Deepens as Teva, Allergan Face Fraud Charges Zacks
08:00AM	Teva Canada Announces Product Availability of AJOVY Business Wire
Aug-18-20 11:03PM	U.S. Government Sues Teva Pharmaceutical for Alleged Drug Kickbacks Motley Fool -9.58%
05:04PM	Stock Markets Hit New Records; Retail Stocks, Teva Take Hits Motley Fool
03:32PM	Tevas Stock Slides After U.S. Sues Over Copay Kickback Claims Barrons.com
03:25PM	Here's Why Teva Pharmaceutical Fell as Much as 15.4% Today Motley Fool
02:07PM	New York charges Teva, Allergan with insurance fraud over opioid claims Reuters
02:01PM	New York files insurance fraud charges against opioid makers Teva, Allergan Reuters
01:38PM	(TEVA) Alert: Johnson Fistel Launches Investigation into Teva Pharmaceutical; Investors Suffering Losses Encouraged to Contact Firm GlobeNewswire
11:59AM	Teva's stock sinks 10% on False Claims allegations MarketWatch
11:53AM	Teva Sued by U.S. Government Over Alleged Copaxone Kickbacks TheStreet.com
10:19AM	U.S. sues Teva over alleged kickbacks for multiple sclerosis drug Reuters
10:01AM	U.S. sues Teva over alleged kickbacks for multiple sclerosis drug Reuters
Aug-13-20 01:15PM	Pharmacy to pay $3.5 mln to resolve U.S. claims it helped Teva pay kickbacks Reuters
Aug-11-20 02:12PM	Do Institutions Own Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares? Simply Wall St.
Aug-06-20 01:42PM	Early Sales of Eli Lilly's Migraine Drug Disappoint GuruFocus.com
01:22PM	Teva's Litigation Risks Weigh Against Stabilizing Fundamentals, Analyst Says Benzinga
09:09AM	Teva (TEVA) Q2 Earnings Top, Stock Up Despite Coronavirus Woes Zacks
Aug-05-20 04:47PM	Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. Barrons.com +7.29%
07:59AM	Kodak Has People Talking Again. Heres What Its Stock Might Be Worth. Barrons.com
07:45AM	Recap: Teva Pharmaceutical Q2 Earnings Benzinga
07:30AM	Teva (TEVA) Q2 Earnings Beat, Sales Miss, Keeps 2020 View Zacks
07:19AM	Teva Pharm second-quarter profit tops forecast, reaffirms 2020 outlook Reuters
07:11AM	Teva Pharm Q2 profit slightly beats profit forecast Reuters
07:10AM	Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market Business Wire
07:00AM	Teva Reports Second Quarter 2020 Financial Results Business Wire
02:01AM	Corcept Therapeutics Incorporated (CORT) Q2 2020 Earnings Call Transcript Motley Fool
Aug-03-20 11:26AM	Teva (TEVA) to Report Q2 Earnings: What's in the Cards? Zacks +5.63%
Jul-31-20 03:01AM	Deckers Outdoor Corp (DECK) Q1 2021 Earnings Call Transcript Motley Fool
Jul-30-20 02:00AM	Teva Announces New Strategic Focus in the Japanese Market Business Wire
Jul-29-20 08:00AM	Teva Announces New Drug Application Filing in Japan for AJOVY® (fremanezumab) Injection Business Wire
Jul-27-20 02:27PM	U.S. judge rejects imposing attorney fee levy on opioid lawsuit settlements Reuters
Jul-16-20 05:34PM	Brazilian waste management firm finds cost-cutting users in pandemic Reuters
Jul-15-20 05:51AM	Got $1,000? Buy These 4 Beaten-Down Stocks Right Now Motley Fool +8.28%
Jul-13-20 08:30AM	Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer GlobeNewswire
08:00AM	Teva Announces Availability of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD Business Wire
Jul-12-20 12:53PM	Did Hedge Funds Make The Right Call On Teva Pharmaceutical Industries Limited (NYSE:TEVA) ? Insider Monkey
Jul-09-20 04:00PM	Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. ET on August 5, 2020 Business Wire
09:26AM	The Zacks Analyst Blog Highlights: Canadian Solar, Office Depot and Teva Pharmaceutical Industries Zacks
Jul-08-20 11:52AM	Sometimes, Valuation Is the Most Important Consideration Zacks
Jul-05-20 06:56AM	Warren Buffett's 3 Biggest Winners in the First Half of 2020: Are They Still Buys Now? Motley Fool
Jul-03-20 08:07AM	Choose These 5 Price-to-Book Value Stocks for High Returns Zacks
Jul-02-20 05:51AM	Here's My Single Best Investment Idea for July Motley Fool
Jul-01-20 11:50AM	Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now? Zacks -6.65%
11:30AM	Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year? Zacks
07:21AM	My Top 5 Portfolio Holdings for the Second Half of 2020 Motley Fool
Jun-18-20 08:00AM	Teva Presents New Analyses Examining Changes in Migraine Disability Outcome Measurements with AJOVY® (fremanezumab-vfrm) Injection Business Wire
Jun-15-20 03:20PM	FDA Revokes Emergency Use Status Of Hydroxychloroquine, Hyped By Trump For Coronavirus Benzinga
02:28PM	Drug Stock Due for Another Climb on the Charts Schaeffer's Investment Research
11:50AM	Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now? Zacks
11:30AM	Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year? Zacks
08:00AM	Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection Open-Label Extension Study at American Headache Society Annual Meeting Business Wire
Jun-12-20 05:50PM	Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know Zacks
Jun-09-20 07:30AM	NIRI Philadelphia Elects New Board Members GlobeNewswire
06:06AM	3 Buffett Stocks That Are Still Historically Cheap Motley Fool
Jun-08-20 04:14PM	Teva Wins Narcan Patent Battle Sending Its Biotech Rivals Plunging Investor's Business Daily
Jun-07-20 03:36AM	Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan Nasal Spray SmarterAnalyst
Jun-05-20 12:48PM	Hope dims for hydroxychloroquine even as medical study detailing the drugs failure is retracted MarketWatch
Jun-02-20 08:00AM	Teva Showcases Global Impact in 2019 Environmental, Social and Governance Progress Report Business Wire
May-31-20 07:40AM	3 Buffett Stocks That Are Trouncing Berkshire Hathaway So Far This Year Motley Fool
06:35AM	2 Pharmaceutical Stocks Trading Below Their Book Value Motley Fool
May-30-20 06:30AM	Is Teva Pharmaceuticals Stock a Buy? Motley Fool
May-29-20 11:50AM	Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock? Zacks
06:40AM	Cramer Shares His Thoughts On Teva, Oxford Industries And More Benzinga
May-27-20 05:51AM	Got $3,000? These 5 Beaten-Down Stocks Are Begging to Be Bought Motley Fool
May-26-20 08:00AM	Teva Announces Virtual 2020 Annual Meeting of Shareholders Business Wire
May-25-20 02:00AM	Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine Business Wire

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Daniell Richard	Exec. VP, European Commercial	Sep 09	Sale	8.98	333	2,992	10,765	Sep 10 09:04 AM
Crane Rosemary A	Director	Aug 11	Sale	11.90	2,860	34,038	33,509	Aug 13 04:07 PM
Griffin Deborah A	Chief Accounting Officer	Mar 17	Sale	7.16	944	6,762	0	Mar 19 08:09 AM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 17	Sale	7.16	2,359	16,899	2,974	Mar 19 07:38 AM
O'Grady Brendan P.	EVP, North America Commercial	Mar 17	Sale	7.16	470	3,367	14,868	Mar 19 07:37 AM
Nazzi Gianfranco	EVP, International Markets	Mar 17	Sale	7.17	345	2,474	19,844	Mar 19 07:36 AM
Fridriksdottir Hafrun	Executive VP, Global R&D	Mar 17	Sale	7.16	514	3,682	45,561	Mar 19 07:33 AM
Daniell Richard	Exec. VP, European Commercial	Mar 17	Sale	7.17	616	4,418	10,400	Mar 19 07:31 AM
Griffin Deborah A	Chief Accounting Officer	Mar 04	Sale	11.23	4,807	53,980	0	Mar 05 08:16 AM
O'Grady Brendan P.	EVP, North America Commercial	Mar 03	Sale	11.37	463	5,262	14,159	Mar 05 08:13 AM
Nazzi Gianfranco	EVP, International Markets	Mar 03	Sale	11.77	548	6,448	19,315	Mar 05 08:11 AM
Daniell Richard	Exec. VP, European Commercial	Mar 03	Sale	11.77	991	11,660	9,719	Mar 05 08:07 AM
Griffin Deborah A	Chief Accounting Officer	Mar 03	Sale	11.37	1,166	13,253	0	Mar 04 06:39 AM
Griffin Deborah A	Chief Accounting Officer	Mar 02	Sale	11.60	2,941	34,112	0	Mar 04 06:39 AM
Drape Eric	Executive VP Global Operations	Feb 19	Sale	12.51	8,000	100,080	21,494	Feb 20 07:17 PM
Fridriksdottir Hafrun	Executive VP, Global R&D	Feb 14	Sale	12.14	11,472	139,295	45,061	Feb 18 07:23 AM
Drape Eric	Executive VP Global Operations	Feb 14	Sale	12.14	8,140	98,785	29,494	Feb 18 07:22 AM
Stark David Matthew	Exec. VP Chief Legal Officer	Feb 14	Sale	12.14	17,016	206,612	2,974	Feb 18 07:26 AM
Sabag Mark	See "Remarks" below	Feb 13	Sale	13.03	72,131	939,760	0	Feb 18 07:25 AM
Stark David Matthew	Exec. VP Chief Legal Officer	Feb 10	Sale	12.24	12,538	153,471	2,974	Feb 11 07:06 AM
O'Grady Brendan P.	EVP, North America Commercial	Feb 10	Sale	12.27	4,799	58,884	13,456	Feb 11 07:02 AM
Nazzi Gianfranco	EVP, Growth Markets Commercial	Feb 10	Sale	12.24	4,155	50,864	18,464	Feb 11 07:01 AM
Fridriksdottir Hafrun	Executive VP, Global R&D	Feb 10	Sale	12.27	5,544	68,025	33,330	Feb 11 06:57 AM
Drape Eric	Executive VP Global Operations	Feb 10	Sale	12.24	3,144	38,488	20,618	Feb 11 06:56 AM
Dethlefs Sven	EVP Global Marketing&Portfolio	Feb 10	Sale	12.27	5,669	69,559	18,061	Feb 11 06:53 AM
Daniell Richard	Exec. VP, European Commercial	Feb 10	Sale	12.24	6,199	75,886	8,612	Feb 11 06:52 AM
Fridriksdottir Hafrun	Executive VP, Global R&D	Dec 31	Sale	9.92	2,459	24,396	22,754	Jan 02 06:08 AM
Fridriksdottir Hafrun	Executive VP, Global R&D	Dec 02	Sale	10.49	4,310	45,214	20,573	Dec 03 06:32 AM
McClellan Michael James	EVP, Chief Financial Officer	Nov 05	Sale	8.83	242	2,138	15,898	Nov 06 06:46 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience